Enhancing Fear Extinction via Angiotensin Type 1 Receptor Inhibition: A randomized Controlled Trial in Posttraumatic Stress Disorder

The primary objective of this study is to evaluate the efficacy of losartan during 10 weeks of treatment for adults with posttraumatic stress disorder (PTSD).

Primary Sponsor:
US. Department of Defense

Prinicipal Investigator:
Suzan Song

Contact Phone:
202-741-2443

Are you interested in more information on this clinical trial?

First Name *
Last Name *
Email *
Street Address *
City *
State *
Zip Code *
Phone Number 
     
Verification Code *

Please type what you see (all uppercase):